Page last updated: 2024-11-13

galphimine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

galphimine A: isolated from the Mexican plant Galphimia glauca; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
GalphimiagenusA plant genus of the family MALPIGHIACEAE. G. glauca is the source of 'Galphimia glauca extract' and contains 'galphimine B' and tetragalloylquinic acid.[MeSH]MalpighiaceaeA plant family of the order Polygalales, subclass Rosidae class, Magnoliopsida that are mostly shrubs and small trees. Many of the members contain indole alkaloids.[MeSH]

Cross-References

ID SourceID
PubMed CID21578020
CHEMBL ID522335
MeSH IDM0490527

Synonyms (3)

Synonym
CHEMBL522335
galphimine a
methyl (1s,2r,5s,10s,11s,14s,15s,21r,22r,23s)-10,22,23-trihydroxy-21-[(1r)-1-hydroxyethyl]-2,5,8,14-tetramethyl-18-oxo-19-oxapentacyclo[12.9.0.02,11.05,10.015,21]tricosa-7,16-diene-11-carboxylate

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"The aim of this study was to obtain pharmacokinetic data for the anxiolytic compound galphimine-A (G-A) from Galphimia glauca."( Pharmacokinetic study in mice of galphimine-A, an anxiolytic compound from Galphimia glauca.
Abarca Vargas, R; Aguilar, FA; Herrera-Ruiz, M; Jiménez-Ferrer, E; Tortoriello, J; Zamilpa, A, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID401220Cytotoxicity against human KB cells2004Journal of natural products, Apr, Volume: 67, Issue:4
Isolation of nor-secofriedelanes from the sedative extracts of Galphimia glauca.
AID401222Cytotoxicity against human OVCAR cells2004Journal of natural products, Apr, Volume: 67, Issue:4
Isolation of nor-secofriedelanes from the sedative extracts of Galphimia glauca.
AID401223Cytotoxicity against human SQC1 cells2004Journal of natural products, Apr, Volume: 67, Issue:4
Isolation of nor-secofriedelanes from the sedative extracts of Galphimia glauca.
AID378973Anxiolytic effect in ICR mouse assessed as increase in number of entries on open arm at 15 mg/kg, ip administered 1 hr before by elevated plus-maze test2006Journal of natural products, Jan, Volume: 69, Issue:1
Anxiolytic effect of natural galphimines from Galphimia glauca and their chemical derivatives.
AID401221Cytotoxicity against human HCT15 cells2004Journal of natural products, Apr, Volume: 67, Issue:4
Isolation of nor-secofriedelanes from the sedative extracts of Galphimia glauca.
AID378972Anxiolytic effect in ICR mouse assessed as increase in time spent on open arm at 15 mg/kg, ip administered 1 hr before by elevated plus-maze test2006Journal of natural products, Jan, Volume: 69, Issue:1
Anxiolytic effect of natural galphimines from Galphimia glauca and their chemical derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]